查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1145975

微生物鑑定市場 - COVID-19 的增長、趨勢、影響和預測（2022-2027 年）

Microbial Identification Market - Growth, Trends, and Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計微生物鑑定市場在預測期內的複合年增長率為 7.0%。

COVID-19 爆發對市場產生了重大影響。裁員減少了進出口活動，診斷中心和醫院已經關閉。例如，根據 2021 年 9 月發表的論文《COVID-19 大流行對抗菌素耐藥性的監測、預防和控制的影響：一項全球調查》，護理、醫療和公共衛生人員減少了 71% ，分別為 69% 和 64%。然而，隨著 COVID-19 限制的解除以及行業診斷和測試服務的恢復，預計研究中的市場將在預測期內增長。

推動市場增長的特定因素包括傳染病負擔的增加、微生物鑑定的技術進步、食品安全問題的增加以及政府為促進微生物鑑定而採取的舉措和資金。

傳染病的日益流行是推動市場增長的關鍵因素。例如，根據世界衛生組織發布的《2021年全球結核病報告》的數據，大多數結核病病例發生在東南亞（43%）、非洲（25%）和西太平洋（18%）。東地中海（8.3%）、美洲（3.0%）和歐洲（2.3%）報告的肺結核病例數較低。同樣，根據世界衛生組織 (WHO) 2021 年發布的數據，撒哈拉以南非洲地區繼續承受瘧疾負擔，約佔所有病例的 95% 和所有死亡人數的 96%。因此，越來越多的傳染病病例將增加對微生物鑑定的需求，預計市場將出現高速增長。

此外，包裝和未包裝食品中日益增加的食品安全問題也促進了市場增長。如今，人們正在轉向食用微生物污染風險更高的加工食品。例如，2020年12月，Nutrition and Diabetes發表了一篇題為《澳大利亞成年人口中的超加工食品消費與肥胖問題》的論文，發現他食用快餐菜餚、甜包子、包子、蛋糕等加工食品, 和垃圾食品。因此，此類加工食品的高消費預計將增加對微生物鑑定的需求，以向公眾提供安全和優質的食品。

此外，世界衛生組織 2022 年 5 月發布的數據顯示，每年估計有 6 億人因食用受污染的食物而生病，並有 42 萬人死亡。在低收入和中等收入國家，不安全食品每年造成 1100 億美元的生產力損失和醫療保健費用。因此，食品污染髮生率的上升增加了對食品檢測以檢測特定致病微生物的需求。

此外，2020 年，世界衛生大會呼籲世界衛生組織報告到 2025 年全球食源性疾病負擔的最新發病率、死亡率和疾病負擔估計值。通過了一項新決議。該決議授權世衛組織在國家、區域和國際各級監測食源性疾病和人畜共患病的全球負擔。這些政府舉措也有助於市場的增長。

但是，在預測期內，自動化微生物識別系統的高成本可能會阻礙市場增長。

主要市場趨勢

儀器推動產品和服務領域的增長

由於傳染病負擔增加、微生物鑑定意識增強以及技術先進產品的出現等因素，預計設備細分市場在預測期內將出現顯著增長。

多年來，可識別生物的範圍已擴大到包括更廣泛的微生物菌株。這包括使用質譜 (MS) 從臨床標本中快速識別分離細菌的技術。

隨著傳染病的流行，越來越需要識別導致它們的微生物。例如，根據世界衛生組織2022年7月公佈的數據，加納阿散蒂地區報告了兩例馬爾堡病毒病（MVD）死亡病例，隨後馬爾堡病毒檢測呈陽性。此外，2022 年 4 月發布的消息表明，佛羅裡達州爆發了 C 群腦膜炎球菌病，主要發生在與其他男性發生性關係的男性中，包括 HIV 陽性的男性。據信具有影響力。

此外，企業在微生物鑑定產品開發方面的活動不斷增加，預計也將在預測期內推動細分市場的增長。例如，2021 年 7 月，布魯克公司將為其 MALDI Biotyper (MBT) 平台推出一種新產品和方法，即 MALDI Biotyper Sirius，用於從培養板和陽性血培養中進行快速、近乎通用的“蛋白質組指紋”。並支持具有成本效益的微生物鑑定工作流程。同樣在 2021 年 4 月，生物梅裡埃的下一代 MALDI-TOF 質譜系統 VITEK MS PRIME 獲得了 CE 標誌，可在幾分鐘內進行常規微生物鑑定。

因此，由於上述因素，預計該市場將在預測期內增長。

北美市場份額最大

由於傳染病和流行病的爆發、醫療保健成本上升以及已建立的醫療保健基礎設施的存在等因素，預計北美將在預測期內主導微生物鑑定市場。

該地區的傳染病流行已成為推動市場增長的關鍵因素。

根據醫療保險和醫療補助服務中心於 2022 年 3 月發布的題為“精算師 CMS 辦公室發布的 2021-2030 年國家衛生支出預測”的數據，2021 年至 2030 年國家衛生支出的年增長率預計為平均 5.1%。 2020年，全國醫療保健支出為4.1萬億美元，預計2030年將達到6.8萬億美元。因此，預計增加醫療保健支出將增加企業活動和政府在開發技術先進的測試產品和儀器方面的舉措，從而推動市場增長。

此外，技術先進產品的興起和該地區主要市場參與者的存在也有望在預測期內推動市場增長。例如，2022 年 1 月，BD Kiestra IdentifA 系統獲得了美國食品和藥物管理局的 510(k) 許可，該系統旨在自動化微生物細菌鑑定測試的準備工作。同樣在 2021 年 1 月，布魯克將推出 MBT Sepsityper Kit US IVD，用於從 MALDI Biotyper CA 系統上的陽性血培養物中快速鑑定超過 425 種生物體。

因此，由於上述因素，研究中的市場預計將在預測期內增長。

競爭格局

這個市場既有全球公司，也有本地公司，所以競爭很低。一些公司目前在市場上佔有健康的份額。例如，Thermofisher Scientific、BioMerieux SA、Beckman Coulter Inc.、Shimadzu Corporation、Becton、Dickinson and Company 是市場的主要參與者，還有擁有大量份額的本地和中小企業。

其他特典

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第 1 章介紹

  • 研究假設和市場定義
  • 調查範圍

第 2 章研究方法

第 3 章執行摘要

第 4 章市場動態

  • 市場概覽
  • 市場促進因素
    • 增加傳染病負擔
    • 微生物鑑定技術進展
    • 對食品安全的擔憂日益增加
    • 政府為促進微生物檢測所做的努力和資助
  • 市場抑制因素
    • 自動微生物鑑定系統成本高
  • 波特五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按產品/服務
    • 設備
    • 消耗品
    • 按服務
  • 按方法
    • 表型法
    • 基因分型方法
    • 基於蛋白質組學的方法
  • 按應用
    • 診斷
    • 食品和飲料檢驗
    • 藥品
    • 化妝品和個人護理產品檢驗
    • 其他應用
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海合會
      • 南非
      • 其他中東和非洲
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第 6 章競爭格局

  • 公司簡介
    • Becton, Dickinson and Company
    • Biolog Inc.
    • BioMerieux SA
    • Bruker Corporation
    • Charles River Laboratories International Inc.
    • Danaher Corporation（Beckman Coulter Inc.）
    • Eurofins Scientific SE
    • Merck Millipore（Merck KGaA）
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • VWR Corporation

第 7 章市場機會和未來趨勢

簡介目錄
Product Code: 64219

The Microbial Identification Market is projected to witness a CAGR of 7.0% over the forecast period.

The COVID-19 outbreak has had a significant impact on the market. As employment closures have curtailed import and export activities and closures of diagnostics centers and hospitals. For instance, according to an article titled "Impact of the COVID-19 pandemic on the surveillance, prevention, and control of antimicrobial resistance: a global survey" published in September 2021, there was a reduction in the availability of the nursing, medical, and public health staff for antimicrobial resistance by 71%, 69%, and 64%, respectively. However, with the release COVID-19 restrictions and resumed diagnosis and testing services in industries the studied market is expected to grow over the forecast period.

Certain factors propelling the market growth are the rising burden of infectious diseases, technological advancements in microbial identification, increasing food safety concerns, and government initiatives and funding for promoting microbial identification.

The increasing prevalence of infectious diseases is the key factor driving market growth. For instance, according to the data published by the World Health Organization in the Global Tuberculosis Report 2021, most of the tuberculosis cases were found in the World Health Organization (WHO) regions of South-East Asia (43%), Africa (25%) and the Western Pacific (18%), and lesser numbers of tuberculosis cases were found in Eastern Mediterranean (8.3%), the Americas (3.0%) and Europe (2.3%). Similarly, according to the World Health Organization (WHO) data published in 2021, Sub-Saharan Africa likely continues to endure the burden of malaria, accounting for approximately 95% of all cases and 96% of all deaths. Thus, rising cases of infectious diseases are expected to increase the demand for microbial testing resulting in the high growth of the market.

Additionally, the growing food safety concerns in packed and non-packed food are also contributing to the market growth. The population nowadays is more shifting toward consuming processed foods which have a high risk of microbial contamination. For instance, according to an article published by Nutrition and Diabetes, in December 2020, titled 'Ultra-processed food consumption and obesity in the Australian adult population", it has been found that 80% of the adults in Australia consumed processed or junk food, such as mass-produced packaged bread, ready meals, fast food dishes and pastries, buns and cakes, in their daily life. Thus, the high consumption of this processed food by the population is expected to increase the demand for microbial testing to deliver safe and quality food to the population.

Furthermore, as per the data published by the World Health Organization in May 2022, an estimated 600 million people fall ill eating contaminated food and 420 000 die every year. In addition, USD 110 billion is lost each year in productivity and medical expenses resulting from unsafe food in low- and middle-income countries.Thus, the rising incidences of food contamination has increased the need for food testing for detecting specific microbes causing diseases.

Moreover, in 2020, the World Health Assembly passed a new resolution requiring the World Health Organization to report on the global burden of foodborne diseases by 2025 with the most recent estimates of incidence, mortality, and disease burden. The resolution mandates WHO to monitor the global burden of foodborne and zoonotic diseases at national, regional, and international levels. Such initiatives by the government are also contributing to market growth.

However, the high cost of automated microbial identification systems is likely to impede the market growth over the forecast period.

Key Market Trends

Instruments are Driving the Product and Service Segment's Growth

The instrument segment is expected to witness significant growth in the studied market over the forecast period owing to the factors such as the rising burden of infectious diseases, growing awareness regarding microbial testing, and emerging technologically advanced products.

The range of the distinguishable organism has expanded over the years to include a wider range of microorganism strains. These include techniques for rapid isolated-organism identification using mass spectrometry (MS) in clinical specimens.

With the increasing prevalence of infectious diseases, there is an increasing need to identify the microorganism causing them. For instance, as per the World Health Organization data published in July 2022, two fatal cases of Marburg virus disease (MVD) were reported from the Ashanti region, Ghana, and were later tested positive for Marburg virus. Additionally, as per a news published in April 2022, in Florida, there has been a significant serogroup C meningococcal disease outbreak, mostly affecting men who have intercourse with other men, including those who are HIV-positive.

Additionally, the rising company activities in developing microbial testing products are also expected to boost segment growth over the forecast period. For instance, in July 2021, Bruker Corporation launched new products and methods for the MALDI Biotyper (MBT) platform, MALDI Biotyper Sirius, that supports workflows for the rapid, nearly universal and cost-effective microbial identification by 'proteomic fingerprinting' from culture plates and from positive blood cultures. Also, in April 2021, bioMerieux received CE-marking of VITEK MS PRIME, the next generation of the VITEK MS MALDI-TOF mass spectrometry system for routine microbial identification in minutes.

Thus, owing to the aforementioned factors, the studied market is expected to grow over the forecast period.

North America Accounts for the Largest Share in the Market

North America is expected to dominate the microbial identification market over the forecast period owing to the factors such as the rising burden of infectious diseases and outbreaks of epidemics, growing healthcare expenditure, and the presence of well-established healthcare infrastructure.

The increasing prevalence of infectious diseases in the region is the key factor fuelling the market growth. For instance,

As per the data published by the Centers for Medicare & Medicaid Services, in March 2022, titled "CMS Office of the Actuary Releases 2021-2030 Projections of National Health Expenditures", it has been observed that the annual growth in national health spending is expected to be average 5.1% over 2021-2030. Also, the National Health Spending in 2020 was USD 4.1 trillion and it is projected to reach USD 6.8 trillion by 2030. Thus, the increasing healthcare spending is expected to increase company activities and government initiatives in developing technologically advanced testing products and equipment, thereby propelling the market growth.

In addition, rising technologically advanced products and the presence of key market players in the region are also expected to boost market growth over the forecast period. For instance, in January 2022, BD received 510(k) clearance from the United States Food and Drug Administration for BD Kiestra IdentifA system which is designed to automate the preparation of microbiology bacterial identification testing. Also, in January 2021, Bruker Corporation launched MBT Sepsityper Kit US IVD for rapid microbial identification of more than 425 microorganisms from positive blood cultures on the MALDI Biotyper CA System.

Thus, owing to the aforementioned factors, the studied market is expected to grow over the forecast period.

Competitive Landscape

The market studied is moderately competitive, with the presence of both global and local players. Few companies currently hold a healthy share of the market. For instance, Thermofisher Scientific, BioMerieux SA, Beckman Coulter Inc., Shimadzu Corporation, and Becton, Dickinson and Company are the major players in the market, along with local and smaller companies that hold a substantial share.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Infectious Diseases
    • 4.2.2 Technological Advancements in Microbial Identification
    • 4.2.3 Increasing Food Safety Concerns
    • 4.2.4 Government Initiatives and Funding for Promoting Microbial Identification
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Automated Microbial Identification Systems
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Products and Services
    • 5.1.1 Instruments
    • 5.1.2 Consumables
    • 5.1.3 Services
  • 5.2 By Method
    • 5.2.1 Phenotypic Methods
    • 5.2.2 Genotypic Methods
    • 5.2.3 Proteomics-based Methods
  • 5.3 By Application
    • 5.3.1 Diagnostics
    • 5.3.2 Food and Beverage Testing
    • 5.3.3 Pharmaceuticals
    • 5.3.4 Cosmetics and Personal Care Products Testing
    • 5.3.5 Other Applications
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Becton, Dickinson and Company
    • 6.1.2 Biolog Inc.
    • 6.1.3 BioMerieux SA
    • 6.1.4 Bruker Corporation
    • 6.1.5 Charles River Laboratories International Inc.
    • 6.1.6 Danaher Corporation (Beckman Coulter Inc.)
    • 6.1.7 Eurofins Scientific SE
    • 6.1.8 Merck Millipore (Merck KGaA)
    • 6.1.9 Shimadzu Corporation
    • 6.1.10 Thermo Fisher Scientific Inc.
    • 6.1.11 VWR Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS